Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 0 | 0 | 9 | 9 | 18,009 |
| Gross Profit | N/A | N/A | 9 | 9 | 18,009 |
| Operating Expenses | 684 | 629 | 16,880 | 19,116 | 16,582 |
| Operating Income | -684 | -629 | -16,871 | -19,107 | 1,427 |
| Interest Expense | 0 | 0 | 754 | 746 | 742 |
| Other Income | -6 | -1 | 541 | 440 | 441 |
| Pre-tax Income | -690 | -630 | -17,084 | -19,413 | 1,126 |
| Income Tax | N/A | N/A | N/A | 190 | 1,509 |
| Net Income Continuous | -690 | -630 | -17,084 | -19,603 | -383 |
| Net Income | $-690 | $-630 | $-17,084 | $-19,603 | $-383 |
| EPS Basic Total Ops | -8.25 | -7.50 | -277.36 | -359.82 | -7.50 |
| EPS Basic Continuous Ops | -8.18 | -7.47 | -277.91 | -362.34 | -7.20 |
| EPS Diluted Total Ops | -8.25 | -7.50 | -277.36 | -359.82 | -7.50 |
| EPS Diluted Continuous Ops | -8.18 | -7.47 | -277.91 | -362.34 | -7.20 |
| EBITDA(a) | $-684 | $-629 | $-16,696 | $-19,037 | $1,598 |